Literature DB >> 9255711

A residence-time distribution analysis of the hydrodynamics within the intestine in man during a regional single-pass perfusion with Loc-I-Gut: in-vivo permeability estimation.

H Lennernäs1, I D Lee, U Fagerholm, G L Amidon.   

Abstract

The goal of this study was to determine the most appropriate hydrodynamic model for the Loc-I-Gut in-vivo perfusion system. The general mixing-tank-in-series model, which can approximate single mixing tank and laminar and plug-flow hydrodynamics, was fitted to the observed experimental residence-time distribution curves for the non-absorbable marker [14C]PEG 4000. The residence-time distribution analysis shows that the hydrodynamics of the perfusion solution within the jejunal segment in man is well approximately by a model containing on average between 1-2 mixing tanks in series. The solution is well mixed when using perfusion rates of 2.0, 3.0 and 6.0 mL min-1. The average mean residence time estimates from the fitted residence-time distribution were 12 +/- 7.6, 15 +/- 4.2 and 7.7 +/- 4.6 min, respectively, at these three perfusion rates. The mean volumes of the segment (Vs) were 25 +/- 15, 45 +/- 12 and 46 +/- 27 mL, respectively. There were no statistical differences between 2.0, 3.0 and 6.0 mL min-1 in respect of the number of mixing tanks (n) and mean residence times. This residence-time distribution analysis indicates that the luminal fluid in the Loc-I-Gut perfusion system is well-mixed, and that permeability calculations based on the well-mixed assumption most closely approximate the actual local (average) membrane permeability within the perfused segment.

Entities:  

Keywords:  Non-programmatic

Mesh:

Year:  1997        PMID: 9255711     DOI: 10.1111/j.2042-7158.1997.tb06092.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  9 in total

1.  Human jejunal permeability of two polar drugs: cimetidine and ranitidine.

Authors:  N Takamatsu; O N Kim; L S Welage; N M Idkaidek; Y Hayashi; J Barnett; R Yamamoto; E Lipka; H Lennernäs; A Hussain; L Lesko; G L Amidon
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

2.  The effect of ketoconazole on the in vivo intestinal permeability of fexofenadine using a regional perfusion technique.

Authors:  Christer Tannergren; Tina Knutson; Lars Knutson; Hans Lennernäs
Journal:  Br J Clin Pharmacol       Date:  2003-02       Impact factor: 4.335

Review 3.  Population-based mechanistic prediction of oral drug absorption.

Authors:  Masoud Jamei; David Turner; Jiansong Yang; Sibylle Neuhoff; Sebastian Polak; Amin Rostami-Hodjegan; Geoffrey Tucker
Journal:  AAPS J       Date:  2009-04-21       Impact factor: 4.009

4.  A clinical single-pass perfusion investigation of the dynamic in vivo secretory response to a dietary meal in human proximal small intestine.

Authors:  Eva M Persson; Ralf G Nilsson; Göran I Hansson; Lars J Löfgren; Fredrik Libäck; Lars Knutson; Bertil Abrahamsson; Hans Lennernäs
Journal:  Pharm Res       Date:  2006-02-22       Impact factor: 4.200

5.  Jejunal absorption and metabolism of R/S-verapamil in humans.

Authors:  R Sandström; A Karlsson; L Knutson; H Lennernäs
Journal:  Pharm Res       Date:  1998-06       Impact factor: 4.200

6.  Translating Human Effective Jejunal Intestinal Permeability to Surface-Dependent Intrinsic Permeability: a Pragmatic Method for a More Mechanistic Prediction of Regional Oral Drug Absorption.

Authors:  Andrés Olivares-Morales; Hans Lennernäs; Leon Aarons; Amin Rostami-Hodjegan
Journal:  AAPS J       Date:  2015-05-19       Impact factor: 4.009

7.  Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator.

Authors:  Udoamaka Ezuruike; Mian Zhang; Amita Pansari; Mailys De Sousa Mendes; Xian Pan; Sibylle Neuhoff; Iain Gardner
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-04-18

Review 8.  Intestinal absorption of BCS class II drugs administered as nanoparticles: A review based on in vivo data from intestinal perfusion models.

Authors:  David Dahlgren; Erik Sjögren; Hans Lennernäs
Journal:  ADMET DMPK       Date:  2020-09-17

9.  Use of in-silico assays to characterize the ADMET profile and identify potential therapeutic targets of fusarochromanone, a novel anti-cancer agent.

Authors:  Madison Wynne El-Saadi; Tara Williams-Hart; Brian A Salvatore; Elahe Mahdavian
Journal:  In Silico Pharmacol       Date:  2015-06-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.